News

Shares of TTM Technologies (TTMI) have gained 2.8% over the past four weeks to close the last trading session at $44.57, but there could still be a solid upside left in the stock if short-term price

After reaching an important support level, CVB Financial Corporation (CVBF) could be a good stock pick from a technical perspective. CVBF recently experienced a "golden cross" event, which saw its

Deluxe (DLX) closed the last trading session at $19.66, gaining 26.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Syndax Pharmaceuticals (SNDX) closed the last trading session at $16.33, gaining 63.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Beyond, Inc. (BBBY) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, BBBY's 50-day simple moving average broke out above its

Passage Bio, Inc. (PASG) closed the last trading session at $7.13, gaining 24.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

The Beachbody Company, Inc. (BODI) closed the last trading session at $5.51, gaining 40.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Bar Harbor Bankshares, Inc. (BHB) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, BHB's 50-day simple moving average broke out

Shares of Nexxen International Ltd. Sponsored ADR (NEXN) have gained 0.1% over the past four weeks to close the last trading session at $10.03, but there could still be a solid upside left in the

Shares of CI&T Inc. (CINT) have gained 2.3% over the past four weeks to close the last trading session at $5.44, but there could still be a solid upside left in the stock if short-term price targets

After reaching an important support level, Y-mAbs Therapeutics, Inc. (YMAB) could be a good stock pick from a technical perspective. YMAB recently experienced a "golden cross" event, which saw its

Ranpak Holdings Corp (PACK) closed the last trading session at $5.28, gaining 52.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Guardian Pharmacy Services, Inc. (GRDN) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, GRDN's 50-day simple moving average broke

Shares of DoubleDown Interactive Co., Ltd. Sponsored ADR (DDI) have gained 4.8% over the past four weeks to close the last trading session at $9.65, but there could still be a solid upside left in

Foghorn Therapeutics Inc. (FHTX) closed the last trading session at $5.06, gaining 1.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Arcturus Therapeutics Holdings Inc. (ARCT) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, ARCT's 50-day simple moving

Arcutis Biotherapeutics, Inc. (ARQT) closed the last trading session at $15.52, gaining 8.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Shares of ARKO Corp. (ARKO) have gained 25.3% over the past four weeks to close the last trading session at $5, but there could still be a solid upside left in the stock if short-term price targets

Shares of XOMA Royalty (XOMA) have been struggling lately and have lost 5.1% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the

Shares of Ascentage Pharma Group International - Unsponsored ADR (AAPG) have been struggling lately and have lost 11.3% over the past week. However, a hammer chart pattern was formed in its last

After reaching an important support level, S&T Bancorp, Inc. (STBA) could be a good stock pick from a technical perspective. STBA recently experienced a "golden cross" event, which saw its 50-day

The price trend for Puma Biotech (PBYI) has been bearish lately and the stock has lost 12% over the past two weeks. However, the formation of a hammer chart pattern in its last trading session

Shares of Amneal Pharmaceuticals (AMRX) have gained 22.1% over the past four weeks to close the last trading session at $9.56, but there could still be a solid upside left in the stock if short-term

Abbott Laboratories ABT recently received CE Mark in Europe for an expanded indication for its Navitor transcatheter aortic valve implantation (TAVI) system to treat people with symptomatic, severe

The Boeing Company’s (BA) defense business has been a stabilizing pillar for the aerospace giant as its commercial division, despite showing growth traits lately, continues to face supply-chain and